Delivering trials in the NHS: more than worth it

Richard Haynes; Marion Mafham; Cheng Hock Toh; Martin J Landray

doi:10.7861/clinmed.2023-0296

Delivering trials in the NHS: more than worth it

Clin Med (Lond). 2023 Sep;23(5):525-526. doi: 10.7861/clinmed.2023-0296.

Authors

Richard Haynes¹, Marion Mafham², Cheng Hock Toh³, Martin J Landray⁴

Affiliations

¹ Nuffield Department of Population Health, University of Oxford, Oxford, UK, and chief scientist, Protas, Salford, UK.
² Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³ University of Liverpool, Liverpool, UK, and honorary consultant in haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
⁴ Nuffield Department of Population Health, University of Oxford, Oxford, UK, and chief executive officer, Protas, Salford, UK martin.landray@ndph.ox.ac.uk.

Abstract

Randomised trials are the best method to determine the efficacy and safety of health technologies. A recent report by Lord O'Shaughnessy highlighted many of the current challenges to delivering trials in the UK and proposed potential solutions. Among these, making trials the business of all NHS institutions and a valued part of all doctors' work, while leveraging the potential of the data that the NHS collects routinely, offers an opportunity to improve NHS efficiency, doctors' job satisfaction and population health simultaneously.

Keywords: NHS; clinical research; randomised trials.

MeSH terms

Attitude of Health Personnel
Humans
Job Satisfaction
Physicians*
State Medicine*

Grants and funding

WT_/Wellcome Trust/United Kingdom